BofA Global Research raises Novavax price objective to $8 from $7
NVAX•BofA Global Research raised its price objective for Novavax to $8 from $7.
Related News
Nasdaq trading halt: volatility trading pause at 10:10 a.m.
CD•
Zedge names Morris Berger CEO effective Oct. 1, 2026
ZDGE•
Nasdaq trade halt: volatility trading pause at 10:08 a.m.
AIOK•
Alignment Healthcare cut to neutral from buy at BofA Global Research; price objective cut to $9 from $25
ALHC•
First Bancshares Missouri Q3 net interest income rises on loan growth
FBSI•